Effect of gymnema sylvestre administration on metabolic syndrome, insulin sensitivity, and insulin secretion

Journal of Medicinal Food

Volumn 20, Issue 8, 2017, Pages 750-754

  Zuñiga, Laura Y ^a   González Ortiz, Manuel ^a   Martínez Abundis, Esperanza ^a  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

Author keywords

body weight; Gymnema sylvestre; insulin resistance; insulinogenic index; Matsuda index

Indexed keywords

CHOLESTEROL; INSULIN; PLANT EXTRACT; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; BLOOD; CHEMISTRY; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; GLUCOSE BLOOD LEVEL; GYMNEMA SYLVESTRE; HUMAN; MALE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL;

ADULT; BLOOD GLUCOSE; CHOLESTEROL; CHOLESTEROL, VLDL; DOUBLE-BLIND METHOD; FEMALE; GYMNEMA SYLVESTRE; HUMANS; INSULIN; MALE; METABOLIC SYNDROME; MIDDLE AGED; PLANT EXTRACTS; TRIGLYCERIDES;

EID: 85027350816     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2017.0001     Document Type: Article

References (26)

1. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute scientific statement: Executive Summary. Crit Pathw Cardiol 2005; 4: 198-203.
2. Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech 2009; 2: 231-237.
3. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-A new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006; 23: 469-480.
4. Bassi N, Karagodin I, Wang S, et al. Lifestyle modification for metabolic syndrome: A systematic review. Am J Med 2014; 127: e1-e10.
5. Grundy SM. Drug therapy of the metabolic syndrome: Minimizing the emerging crisis in polypharmacy. Nat Rev Drug Discov 2006; 5: 295-309.
6. Martínez-Abundis E, Méndez-Del Villar M, Pérez-Rubio KG, et al. Novel nutraceutic therapies for the treatment of metabolic syndrome. World J Diabetes 2016; 7: 142-152.
7. Sinsheimer JE, Rao GS. Constituents from Gymnema sylvestre leaves. VI. Acylated genins of the gymnemic acids-Isolated and preliminary characterization. J Pharm Sci 1970; 59: 629-632.
8. Tiwari P, Mishra BN, Sangwan NS. Phytochemical and pharmacological properties of Gymnema sylvestre: An important medicinal plant. Biomed Res Int 2014; 2014: 830285.
9. Tai MM. A mathematical model for the determination of total area under glucose tolerance and other metabolic curves. Diabetes Care 1994; 17: 152-154.
10. Dalfrà MG, Pacini G, Parretti E, et al. Elevated insulin sensitivity and beta-cell function during pregnancy in mothers of growth-restricted newborns. Am J Physiol Endocrinol Metab 2011; 301: E25-E30.
11. Stumvoll M, Mitrakou A, Pimenta W, et al. Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 2000; 23: 295-301.
12. Abdul-Ghani MA, Matsuda M, Balas B, et al. Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care 2007; 30: 89-94.
13. Jeyaseelan L, Rao PSS: Methods of determining samples size in clinical trials. Indian J Pediatr 1989; 26: 115-121.
14. Ramírez-Vargas E, Arnaud-Viñas MR, Delisle H. Prevalence of the metabolic syndrome and associated lifestyles in adult males from Oaxaca, Mexico. Salud Publica Mex 2007; 49: 94-102.
15. El Shafey AAM, El-Ezabi MM, Seleim MME, et al. Effect of Gymnema sylvestre R. Br. leaves extract on certain physiological parameters of diabetic rats. J King Saud Univ Sci 2013; 25: 135-141.
16. Kim HJ, Hong SH, Chang SH, et al. Effects of feeding a diet containing Gymnema sylvestre extract: Attenuating progression of obesity in C57BL/6J mice. Asian Pac J Trop Med 2016; 9: 437-444.
17. Kumar V, Bhandari U, Tripathi CD, et al. Evaluation of antiobesity and cardioprotective effect of Gymnema sylvestre extract in murine model. Indian J Pharmacol 2012; 44: 607-613.
18. Renga B, Festa C, De Marino S, et al. Molecular decodification of gymnemic acids from Gymnema sylvestre. Discovery of a new class of liver X receptor antagonists. Steroids 2015; 96: 121-131.
19. Shigematsu N, Asano R, Shimosaka M, et al. Effect of longterm administration with Gymnema sylvestre R. BR on plasma and liver lipid in rats. Biol Pharm Bull 2001; 24: 643-649.
20. Al-Romaiyan A, Liu B, Asare-Anane H, et al. A novel Gymnema sylvestre extract stimulates insulin secretion from human islets in vivo and in vitro. Phytother Res 2010; 24: 1370-1376.
21. Manish K, Aditi K, Renu A, et al. Anti-obesity property of hexame extract from the leaves of gymnema sylvestre in high fed cafeteria diet induced obesity rats. IRJP 2011; 2: 112-116.
22. Miller M, Cannon CP, Murphy SA, et al. Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 Trial. J Am Coll Cardiol 2008; 51: 724-730.
23. Khan KA, Dobani S, Shareef MA. Molecular docking and preclinical studies of Gymnema sylvestre on endothelial nitric oxide synthase (ENOS) in type-2 diabetes related complications. J Young Pharm 2014; 6: 25-32.
24. Preuss HG, Jarrell ST, Scheckenbach R, et al.comparative effects of chromium, vanadium and Gymnema sylvestre on sugarinduced blood pressure elevations in SHR. J Am Coll Nutr 2013; 17: 116-123.
25. Bhansali S, Shafiq N, Pandhi P, et al. Effect of a deacyl gymnemic acid on glucose homeostasis & metabolic parameters in a rat model of metabolic syndrome. Indian J Med Res 2013; 137: 1174-1179.
26. Spasov AA, Samokhina MP, Bulanov AE. Antidiabetic properties of Gymnema sylvestre (a review). Pharm Chem J 2008; 42: 626-629.